Opioid Tolerance in Methadone Maintenance Treatment: Comparison of Methadone and Levomethadone in Long-term Treatment

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2016 Feb 17

PMID 26879120

Citations 7

Authors

Stefan Gutwinski

Nikola Schoofs

Heiner Stuke

Thomas G Riemer

Corinde E Wiers

Felix Bermpohl

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to investigate the development of opioid tolerance in patients receiving long-term methadone maintenance treatment (MMT).

Methods: A region-wide cross-sectional study was performed focusing on dosage and duration of treatment. Differences between racemic methadone and levomethadone were examined. All 20 psychiatric hospitals and all 110 outpatient clinics in Berlin licensed to offer MMT were approached in order to reach patients under MMT fulfilling the DSM IV criteria of opiate dependence. In the study, 720 patients treated with racemic methadone or levomethadone gave information on the dosage of treatment. Out of these, 679 patients indicated the duration of MMT.

Results: Treatment with racemic methadone was reported for 370 patients (54.5%), with levomethadone for 309 patients (45.5%). Mean duration of MMT was 7.5 years. We found a significant correlation between dosage and duration of treatment, both in a conjoint analysis for the two substances racemic methadone and levomethadone and for each substance separately. These effects remained significant when only patients receiving MMT for 1 year or longer were considered, indicating proceeding tolerance development in long-term treatment. When correlations were compared between racemic methadone and levomethadone, no significant difference was found.

Conclusions: Our data show a tolerance development under long-term treatment with both racemic methadone and levomethadone. Tolerance development did not differ significantly between the two substances.

Citing Articles

Call for the Standardization of Opioid Related Terminologies.

Liu R, Grothusen J, Barr G Transl Perioper Pain Med. 2025; 11(3):687-688.

PMID: 40041102 PMC: 11879275. DOI: 10.31480/2330-4871/196.

[Challenges in the treatment of opioid dependence].

Heinz A, Gutwinski S, Krausz M, Ernst G, Vogel M, Scherbaum N Nervenarzt. 2024; 95(9):811-817.

PMID: 39008087 DOI: 10.1007/s00115-024-01691-9.

The role of methadone in cardiac surgery for management of postoperative pain.

Edwards J, Whitney M, Smith B, Fah M, Buckner Petty S, Durra O BJA Open. 2024; 10:100270.

PMID: 38560623 PMC: 10978480. DOI: 10.1016/j.bjao.2024.100270.

Lapse and Relapse Rates in Narcotics Anonymous versus Methadone Maintenance Treatment: A 12-Month Prospective Study.

Mohseni F, Rahimi K, Niroumand Sarvandani M, Jamali Z, Seyedhosseini Tamijani S, Rafaiee R Iran J Psychiatry. 2022; 17(1):1-13.

PMID: 35480125 PMC: 8994838. DOI: 10.18502/ijps.v17i1.8044.

New Approaches in Drug Dependence: Opioids.

Mielau J, Vogel M, Gutwinski S, Mick I Curr Addict Rep. 2021; 8(2):298-305.

PMID: 34055568 PMC: 8149259. DOI: 10.1007/s40429-021-00373-9.

References

Magura S, ROSENBLUM A . Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001; 68(1):62-74. View

Freye E, Latasch L . [Development of opioid tolerance -- molecular mechanisms and clinical consequences]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003; 38(1):14-26. DOI: 10.1055/s-2003-36558. View

Faggiano F, Vigna-Taglianti F, Versino E, Lemma P . Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev. 2003; (3):CD002208. DOI: 10.1002/14651858.CD002208. View

DOLE V, Nyswander M, Kreek M . Narcotic blockade--a medical technique for stopping heroin use by addicts. Trans Assoc Am Physicians. 1966; 79:122-36. View

DOLE V, Joseph H . Methadone maintenance. Outcome after termination. N Y State J Med. 1977; 77(9):1409-12. View

DOLE V, Joseph H . Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978; 311:181-9. DOI: 10.1111/j.1749-6632.1978.tb16775.x. View

Milby J . Methadone maintenance to abstinence. How many make it?. J Nerv Ment Dis. 1988; 176(7):409-22. DOI: 10.1097/00005053-198807000-00003. View

Ball J, Lange W, Myers C, Friedman S . Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988; 29(3):214-26. View

Ward J, Darke S, Hall W, Mattick R . Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. Br J Addict. 1992; 87(3):447-53. DOI: 10.1111/j.1360-0443.1992.tb01945.x. View

10.

Wilson P, Watson R, Ralston G . Methadone maintenance in general practice: patients, workload, and outcomes. BMJ. 1994; 309(6955):641-4. PMC: 2541511. DOI: 10.1136/bmj.309.6955.641. View

11.

Caplehorn J, Dalton M, Haldar F, Petrenas A, Nisbet J . Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse. 1996; 31(2):177-96. DOI: 10.3109/10826089609045806. View

12.

Ward J, Hall W, Mattick R . Role of maintenance treatment in opioid dependence. Lancet. 1999; 353(9148):221-6. DOI: 10.1016/S0140-6736(98)05356-2. View

13.

Davis A, Inturrisi C . d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999; 289(2):1048-53. View

14.

DOLE V, NYSWANDER M . A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA. 1965; 193:646-50. DOI: 10.1001/jama.1965.03090080008002. View

15.

Corkery J, Schifano F, Ghodse A, Oyefeso A . The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004; 19(8):565-76. DOI: 10.1002/hup.630. View

16.

Amato L, Davoli M, Perucci C, Ferri M, Faggiano F, Mattick R . An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005; 28(4):321-9. DOI: 10.1016/j.jsat.2005.02.007. View

17.

Inturrisi C . Pharmacology of methadone and its isomers. Minerva Anestesiol. 2005; 71(7-8):435-7. View

18.

Bakker A, Fazey C . Methadone tolerance testing in drug misusers. BMJ. 2006; 333(7577):1056-9. PMC: 1647386. DOI: 10.1136/bmj.39016.471840.68. View

19.

Holtman Jr J, Wala E . Characterization of the antinociceptive and pronociceptive effects of methadone in rats. Anesthesiology. 2007; 106(3):563-71. DOI: 10.1097/00000542-200703000-00022. View

20.

Koch T, Hollt V . Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther. 2007; 117(2):199-206. DOI: 10.1016/j.pharmthera.2007.10.003. View